The presentation of adrenarche is sexually dimorphic and modified by body adiposity.

CONTEXT Adrenarche refers to the onset of increased production of adrenal androgens in childhood leading variably to clinical signs of androgen action. The prevalence and presentation of adrenarche in prepubertal girls and boys is not well known. OBJECTIVE Our objective was to examine the prevalence and clinical presentation of adrenarche in a population sample of prepubertal children aged less than 9 years. DESIGN AND PARTICIPANTS This cross-sectional study included prepubertal children (209 girls and 228 boys; median age 7.6 [range 6.8-8.9] years) taking part in The Physical Activity and Nutrition in Children (PANIC) Study. MAIN OUTCOME MEASURE The prevalence of adrenarche was assessed. RESULTS The prevalence of any clinical sign of androgen action was higher in girls than in boys (26.1% vs 10.0%; P < .001) and biochemical adrenarche without any clinical sign was less common in girls than in boys (8.1% vs 16.7%; P = .007). When premature adrenarche was defined by serum dehydroepiandrosterone sulfate concentration ≥1 μmol/L (≥37 μg/dL) and any clinical sign before the age of 8 years in girls and 9 years in boys, its total prevalence was 8.6% in girls and 1.8% in boys. The risk of having any clinical sign increased with higher body fat percentage in boys and with higher serum dehydroepiandrosterone sulfate concentration in girls. CONCLUSIONS Clinical signs of androgen action are more common, but biochemical adrenarche without any clinical sign is less common in prepubertal girls than boys. This sexual dimorphism of adrenarche might be explained by sex-dependent differences in peripheral androgen metabolism or action that are modified by body fat.

[1]  R. Voutilainen,et al.  Serum androgen bioactivity is low in children with premature adrenarche , 2014, Pediatric Research.

[2]  T. Reinehr,et al.  Steroid hormone profiles in prepubertal obese children before and after weight loss. , 2013, The Journal of clinical endocrinology and metabolism.

[3]  V. Mericq,et al.  Obesity is positively associated with dehydroepiandrosterone sulfate concentrations at 7 y in Chilean children of normal birth weight123 , 2013, The American journal of clinical nutrition.

[4]  A. Šimundić,et al.  Reference intervals for reproductive hormones in prepubertal children on the automated Roche cobas e 411 analyzer. , 2012, Clinical biochemistry.

[5]  T. Laitinen,et al.  Dietary factors associated with overweight and body adiposity in Finnish children aged 6–8 years: the PANIC Study , 2012, International Journal of Obesity.

[6]  T. Barrett,et al.  Premature adrenarche: novel lessons from early onset androgen excess. , 2011, European journal of endocrinology.

[7]  L. Dunkel,et al.  New Finnish growth references for children and adolescents aged 0 to 20 years: Length/height-for-age, weight-for-length/height, and body mass index-for-age , 2011, Annals of medicine.

[8]  R. Voutilainen,et al.  Continuum of phenotypes and sympathoadrenal function in premature adrenarche. , 2009, European journal of endocrinology.

[9]  R. Lipton,et al.  Thelarche, Pubarche, and Menarche Attainment in Children With Normal and Elevated Body Mass Index , 2009, Pediatrics.

[10]  R. Voutilainen,et al.  Androgen receptor gene CAG repeat polymorphism and X-chromosome inactivation in children with premature adrenarche. , 2008, The Journal of clinical endocrinology and metabolism.

[11]  R. Voutilainen,et al.  Childhood metabolic syndrome and its components in premature adrenarche. , 2007, The Journal of clinical endocrinology and metabolism.

[12]  N. Skakkebaek,et al.  Serum sex hormone-binding globulin levels in healthy children and girls with precocious puberty before and during gonadotropin-releasing hormone agonist treatment. , 2007, The Journal of clinical endocrinology and metabolism.

[13]  R. Rosenfield.  Clinical review: Identifying children at risk for polycystic ovary syndrome. , 2007, The Journal of clinical endocrinology and metabolism.

[14]  H. Wilkinson,et al.  Direct agonist/antagonist functions of dehydroepiandrosterone. , 2005, Endocrinology.

[15]  P. Hindmarsh,et al.  Onset of breast and pubic hair development in 1231 preadolescent Lithuanian schoolgirls , 2005, Archives of Disease in Childhood.

[16]  T. Remer,et al.  Urinary markers of adrenarche: reference values in healthy subjects, aged 3-18 years. , 2005, The Journal of clinical endocrinology and metabolism.

[17]  C. Leu,et al.  Partial agonist/antagonist properties of androstenedione and 4-androsten-3β,17β-diol , 2004, The Journal of Steroid Biochemistry and Molecular Biology.

[18]  W. Crowley,et al.  The longitudinal study of adrenal maturation during gonadal suppression: evidence that adrenarche is a gradual process. , 2001, The Journal of clinical endocrinology and metabolism.

[19]  J. Simard,et al.  DHEA and Its Transformation into Androgens and Estrogens in Peripheral Target Tissues: Intracrinology , 2001, Frontiers in Neuroendocrinology.

[20]  G. Koch,et al.  Secondary sexual characteristics and menses in young girls seen in office practice: a study from the Pediatric Research in Office Settings network. , 1997, Pediatrics.

[21]  J. Simard,et al.  DHEA and Peripheral Androgen and Estrogen Formation: Intracrinology , 1995, Annals of the New York Academy of Sciences.

[22]  R. Guglielmi,et al.  Lack of correlation between sex hormone binding globulin, adrenal and peripheral androgens in precocious adrenarche , 1992, Journal of endocrinological investigation.

[23]  L. Dunkel,et al.  Low levels of sex hormone--binding globulin in obese children. , 1985, The Journal of pediatrics.

[24]  James M. Tanner,et al.  Growth at Adolescence , 1956 .

[25]  C. Migeon,et al.  Precocious growth of sexual hair without other secondary sexual development; premature pubarche, a constitutional variation of adolescence. , 1952, Pediatrics.

[26]  R. Voutilainen,et al.  Blood erythrocyte and hemoglobin concentrations in premature adrenarche. , 2013, The Journal of clinical endocrinology and metabolism.